Improving hearing with AI noise reduction in hearing aids
Official title: Evaluation of Artificial Intelligence Based Noise Reduction in Phonak Hearing Aid on Patients With Hearing Impairment and Cochlear Implants
Run by Mayo Clinic · NCT06743295 · Data updated 2026-11-12
This study is testing a new AI noise reduction feature in Phonak hearing aids to see if it helps people with hearing loss hear and understand speech better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 110 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | April 24, 2025 |
| Main results expected | January 1, 2027 |
| Study ends | January 1, 2027 |
| Registry record updated | February 6, 2026 |
| Trial ID | NCT06743295 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with hearing impairment who are either not using hearing aids or currently using them, as well as cochlear implant patients with a single-sided implant.
✕Probably not a fit
Patients with normal hearing or those who do not have hearing impairment may not receive any benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the effectiveness of an artificial intelligence-based noise reduction system integrated into Phonak hearing aids. It will assess whether this technology can provide measurable improvements in hearing and speech perception for individuals with hearing impairment. Participants will include those who do not currently use hearing aids, those who do, and cochlear implant patients with a single-sided implant. The intervention involves the DEEPSONIC™ Deep Sound Optimized Neural Integrated Chip designed to enhance auditory experiences.
Why it matters
Potential benefit: If successful, this could significantly enhance the hearing experience for patients with hearing loss.
How similar studies have gone: Other studies have shown promise in using AI for hearing enhancement, suggesting a potential for success with this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with hearing impairment not using hearing aids * Individuals with hearing impairment currently using hearing aids * Cochlear implant patients with a single-sided implant (using a hearing aid in the opposite ear)
Where it's running
-
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Aniket Saoji, PhD — Mayo Clinic
- Study coordinator: Clinical Research Study Coordinator
- Email: tombers.nicole@mayo.edu
- Phone: 507-293-2445
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
WhatsApp AI support vs paper support for first-time hearing aid users
This study tests whether a WhatsApp-based AI support program helps adults with new hearing aids in LMIC communities use and feel confident about their devices better than a paper pamphlet.
-
Hearing and Brain Development in Children and Teens
This observational study tests how hearing care paths (like hearing aids, cochlear implants, brainstem implants, gene therapy, or no intervention) relate to hearing, speech, language, and brain development in kids and teens, with a normal-hearing group for comparison.
-
Web-based auditory training with easy versus hard task settings to improve speech and listening
This project will test whether easy or hard versions of a web-based auditory training program help adults with hearing loss improve speech understanding and everyday listening.
-
Long-term hearing and speech outcomes after cochlear implants
This project will see if cochlear implants improve hearing, speech understanding, and quality of life in Mandarin-speaking patients of all ages before and after surgery.
-
Clemastine plus engineered sound to improve hearing in noisy environments for age-related central auditory processing disorder
This trial will test whether taking clemastine while listening to engineered sounds helps people aged 45–65 with age-related central auditory processing disorder hear better in noisy places.
-
Add Pedmark to cisplatin chemotherapy to prevent hearing loss in men with stage II–III metastatic testicular germ cell tumors
We will test whether adding Pedmark to cisplatin chemotherapy reduces hearing damage in men with stage II–III metastatic testicular germ cell tumors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.